Aronniemi Johanna, Långström Satu, Mattila Katariina A, Mäkipernaa Anne, Salminen Päivi, Pitkäranta Anne, Pekkola Johanna, Lassila Riitta
University of Helsinki, Yliopistonkatu 4, 00100 Helsinki, Finland.
HUS Diagnostic Center, Department of Radiology, New Children's Hospital, Helsinki University Hospital, P.O. Box 347, Stenbäckinkatu 9, 00029 Helsinki, Finland.
Children (Basel). 2021 Apr 20;8(4):312. doi: 10.3390/children8040312.
Venous malformations (VMs) are congenital low-flow lesions with a wide spectrum of clinical manifestations. An increasing number of studies link VMs to coagulation abnormalities, especially to elevated D-dimer and decreased fibrinogen. This condition, termed localized intravascular coagulopathy (LIC), may pose a risk for hemostatic complications. However, detailed data on the laboratory variables for coagulation and fibrinolytic activity in VM patients are limited. We addressed this question by systematically analyzing the coagulation parameters in pediatric VM patients.
We included 62 patients (median age 11.9 years) with detailed laboratory tests for coagulation and fibrinolytic activity at a clinically steady phase. We assessed clinical and imaging features of VMs and their correlations with coagulation and fibrinolysis variables using patient records and MRI.
D-dimer was elevated in 39% and FXIII decreased in 20% of the patients, as a sign of LIC. Elevated D-dimer and decreased FXIII were associated with large size, deep location, and diffuse and multifocal VMs. FVIII was elevated in 17% of the patients and was associated with small VM size, superficial and confined location, discrete morphology, and less pain. Surprisingly, antithrombin was elevated in 55% of the patients but without associations with clinical or other laboratory variables.
LIC was common in pediatric patients with VMs. Our results provide a basis for when evaluating the risks of hemostatic complications in children with VMs. Further research is warranted to explore the mechanisms behind coagulation disturbances and their relation to clinical complications.
静脉畸形(VMs)是先天性低流量病变,临床表现多样。越来越多的研究将VMs与凝血异常联系起来,尤其是D-二聚体升高和纤维蛋白原降低。这种情况被称为局限性血管内凝血病(LIC),可能会导致止血并发症。然而,关于VM患者凝血和纤溶活性实验室变量的详细数据有限。我们通过系统分析小儿VM患者的凝血参数来解决这个问题。
我们纳入了62例患者(中位年龄11.9岁),这些患者在临床稳定期进行了详细的凝血和纤溶活性实验室检查。我们使用患者记录和MRI评估了VMs的临床和影像学特征及其与凝血和纤溶变量的相关性。
39%的患者D-二聚体升高,20%的患者FXIII降低,这是LIC的表现。D-二聚体升高和FXIII降低与病变体积大、位置深、弥漫性和多灶性VMs有关。1 sevente的患者FVIII升高,且与VM体积小、位置表浅且局限、形态离散和疼痛较轻有关。令人惊讶的是,55%的患者抗凝血酶升高,但与临床或其他实验室变量无关。
LIC在小儿VM患者中很常见。我们的结果为评估小儿VM患者止血并发症风险提供了依据。有必要进一步研究以探索凝血紊乱背后的机制及其与临床并发症的关系。